Iovance Biotherapeutics Overview
Iovance Biotherapeutics Target Price
Where could IOVA trade next? Consensus target price: $7.8.
Get informed when a big investor buys or sells
+ FollowShare Price
$10.02
Average Target Price
$7.83
21.8% downside
21.8% downside6 analysts in the last 4 months
High: $13 | Low: $5
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-20 | UBSDavid Dai | $7 | 30.1% downside |  |
| 2026-08-18 | Mizuho Securities | $11 |  9.8% upside | |
| 2026-08-07 | Robert W. BairdCollen Kusy | $6 | 40.1% downside | |
| 2026-08-07 | Barclays | $13 | 29.7% upside | |
| 2026-06-01 | Wells Fargo | $5 | 50.1% downside | |
| 2026-06-01 | National Bank | $5 | 50.1% downside | |
| 2026-02-05 | Goldman SachsAndrea Newkirk | $2 | 80% downside | |
| 2025-05-16 | UBSDavid Dai | $2 | 80% downside | |
| 2025-02-28 | Piper Sandler | $6 | 40.1% downside | |
| 2025-01-31 | Piper SandlerJoseph Catanzaro | $7.5 | 25.1% downside | |
| 2024-10-24 | UBSDavid Dai | $17 | 69.7% upside | |
| 2024-08-09 | Stifel NicolausBenjamin Burnett | $11.5 | 14.8% upside | |
| 2024-08-09 | Robert W. BairdColleen Kusy | $12 | 19.8% upside | |
| 2024-07-29 | Piper SandlerJoseph Catanzaro | $10 | 0.2% downside | |
| 2024-06-20 | JMP SecuritiesReni Benjamin | $11.5 | 14.8% upside | |
| 2024-05-31 | Stifel NicolausBenjamin Burnett | $14 | 39.7% upside | |
| 2024-03-14 | Piper SandlerJoseph Catanzaro | $19 | 89.6% upside | |
| 2022-12-08 | Goldman SachsMadhu Kumar | $6 | 40.1% downside | |
| 2022-11-20 | Piper SandlerJoseph Catanzaro | $11 | 9.8% upside | |
| 2022-08-23 | Robert W. BairdMichael Ulz | $12.5 | 24.8% upside | |
| 2022-07-01 | Goldman Sachs | $18 | 79.6% upside | |
| 2022-05-27 | Stifel Nicolaus | $13 | 29.7% upside | |
| 2022-04-07 | Robert W. BairdColleen Kusy | $34 | 239.3% upside | |
| 2022-04-05 | Robert W. BairdColleen M. Kusy | $30 | 199.4% upside | |
| 2022-01-28 | Stifel NicolausBenjamin Burnett | $25 | 149.5% upside | |
| 2022-01-05 | Wells FargoNick Abbott | $25 | 149.5% upside | |
| 2021-05-19 | BarclaysPeter Lawson | $40 | 299.2% upside | |